XML 32 R21.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Share-Based Payments: (Tables)
6 Months Ended
Jun. 30, 2024
Equity:  
The following table sets forth information with respect to nonvested options for the three months ended March 31, 2024:

The following table sets forth information with respect to nonvested options for the six months ended June 30, 2024:

 

    Number of Shares     Weighted Average Grant-Date Fair Value  
Nonvested options – beginning of period     122,100     $ 24.47  
Nonvested options granted            
Nonvested options vested or forfeited     (3,200 )   $ 11.90  
Nonvested options – end of period     118,900     $ 24.81  
The following table summarizes stock option information as of March 31, 2024:

The following table summarizes stock option information as of June 30, 2024:

 

    Shares     Weighted Average
Exercise Price
 
             
Outstanding at January 1, 2024     308,970     $ 86.52  
Options forfeited     (200 )     73.09  
Options exercised     (19,620 )     69.81  
                 
Outstanding at June 30, 2024     289,150     $ 87.66  
                 
Options exercisable     170,250     $ 70.60  
Options available for future grants     537,565          
Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2024 and 2023 were as follows:

Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the six months ended June 30, 2024 and 2023 were as follows:

 

(In thousands)   June 30, 2024     June 30, 2023  
             
Cash proceeds from stock options exercised   $ 1,370     $ 5,192  
Tax benefits     224       840  
Intrinsic value of stock options exercised     1,409       5,773